O'Neill Institute  |  September 5, 2019

Read the Publication

Hepatitis C (HCV) cases have increased three-and-a- half times from 2010-2016, primarily due to the increase in injection drug use as the United States grapples with the public health crisis of substance use disorder (SUD). Syringe services programs provide a broad range of harm reduction services and can improve the health of persons who inject drugs including reducing HCV transmission.

Read the Big Idea here.

Related Initiatives

Infectious Diseases

Related Projects

Hepatitis Policy Project